Contents
Executive summary
Chapter 1 - Supply, Demand & Value
From Rentier to Supplier
Over Capacity
Supply Chain Restructuring
Evolutionary or Revolutionary Change
Opportunity not Threat Changing Basis of Competition
Declining R&D Productivity Shortening Effective Lives of Patents
Effectiveness of Patent Protection
Alternative Avenues for Developments
The Supply Side
Adding Value through Supply
Examples from Other Industries
Summary of Opportunities and Challenges References
Chapter 2 - Supply Chain Models
Process Models
Use of Models
Range of Modelling Approaches
Range of Model Types
Sector Specific Characteristics
Pharmaceutical Supply Chain Primer
European Supply Chains
US Supply Chains
Operators in the Value Chain
Efficient Consumer Response
Introduction
Strategies
Category Management
Supply Chain Management
Changing Behaviour
Further European Development of ECR
Critique of ECR
Efficient Healthcare Response
Introduction
Summary
Critique
Supply-Chain Operations Reference (SCOR) Model
Summary
Critique
IBCH Process Classification
Framework
Summary
Critique
References
Chapter 3 - Customer Value
Introduction to Managing Customer Value
Changing Nature of the Customer
Need for the Planning of Customers
Customer Value in Pharmaceutical Supply
Introduction
Most Important Elements of Customer Service
Other Important Elements of Customer Service
Agility Concepts
Introduction
Multiple-niche Competition The Principles Behind the Agile Operator
Process Re-engineering for the Agile company
Product and Service Re-engineering for the Agile Company
Adaptability
Conclusion
Chapter 4 - Shareholder Value and the Supply Chain
Intrinsic Value
Value to Whom?
Searching for Intrinsic Value
Traditional Valuation Methods
Cash-Based Valuation
Economic Value Added
Discounted Cash Flow Techniques
Shareholder Value Management
Origin of Shareholder Value
Value Drivers
Application to the Pharmaceutical Industry
Specific Difficulties
Need for a Separate NPV Calculation
Valuation of a Pipeline using a Decision Tree
Difficulties in Applying the Decision Trees
Cost of Capital
Common Errors in N PV Calculations
Risk
Cost of Capital in the Pharmaceutical industry
References
Chapter 5 - Supply Chain Performance
Use of Maturity Profiles Customer interface
Customers and Markets
Sales and Channels to Market
Product Marketing
Pricing and Promotion
Supply chain
Demand Forecasting
Customer Order Management
Production Scheduling
Materials Management
Supplier Management
Product Distribution
Returns
Invoicing and Credit Control
Receiving Supplier Payment
Production Operations
Production
Maintenance
Process Improvement
Physical Stock Management and Order Dispatch
Design and Commissioning
Route Evaluation and Selection
Facilities Evaluation and Design
Pilot Plant Operations
Construction
Commissioning / validation
Organisational infrastructure
Regulatory Approval
Human Resources / Organisational Behaviour
Information Technology
Financial Management
Business Management
Strategy and Implementation
References
Chapter 6 - Performance Measures
Theory of Measurement
Frameworks
Ideal Behaviour within Supply Chain
Awareness of Performance Measures
Designing a Framework From Measurement to Management3
Building a Strategic Management System
Common Faults of Measures
Measurement Frameworks in Practice
Balanced Scorecard
European Foundation for Quality Management
Intellectual Capital
Frameworks
Do Frameworks Work?
Case Studies from the Pharmaceutical Sector
The Simply Better Way
Balanced Scorecard for Investment Appraisal
Balanced Scorecard for Process Improvement
Collaborative Behaviour within the Supply Chain
Changing Behaviour
Cost Models
Information Flows
Performance Measures
US ECR Scorecard Measures
Other Demand Measures of Supply Chain Collaboration
Other Supply Measures
Enabling Technology Measures
Consumer Measures
References
Chapter 7 - Supply Chain Re-engineering
Objectives of Re-engineering
Commercial Issues
Scope of Re-engineering
Range of Operations
Changing Role of Supply Chain Management
Global Supply Chains
Difficulties
Information Requirements for Global Supply Chains
Reconciliation of Functional Objectives
European Experience
Implementation Survey
Success Factors and Obstacles
Benefits Modelling
Conclusion
Basic Approach
Demand Projections
Service Levels
Manufacturing Capabilities and Flexibilities
Product Flow
Operating Costs
Information Systems
Infrastructure
Performance Measures
Design for Logistics
Supply Chain Re-engineering Case Studies
SmithKline Beecham
Bristol Myers Squib
Eli Lilly
DuPont Merck Pharmaceutical Co
Pfizer
Johnson & Johnson Hospital Services
Pfizer Pharmaceuticals
Bayer Inc
McKesson
Sankyo & Parke-Davis
Eli Lilly
Information Systems
Role of Information Systems
APS Systems Defined
Benefits of APS Systems
Obtaining the Benefits
Actions Required
Changes Required
Obstacles
Information Requirements for Global Supply Chains
Reconciliation of Functional Objectives
As-Is Diagnosis
Strategy & Marker
Customer Service
Products
Supply Chain
Manufacturing Operations
Procurement
Transport
Quality
Overview of Information Systems
Financial
Human Resource
References
Chapter 8 - Process Re-engineering Tool
Principles of Process Re-engineering Controversial Origins and Applications
Common Characteristics
A Typical Approach
Differences in Approach
Business Process Re-Eengineering in Practice
Common Processes
Process Improvement
Process Modelling
Innovation
Technology Push Versus Business Pull
Causes for Failure
Cost to Serve: A Case Study
Introduction
Main Finding
Resultant Action
Project Method
Project Output
Procurement Review
Potential of Out-Sourcing
Business Case for a Purchasing Review
Guidelines for a Purchasing Review
Partnership Sourcing Cost Management at the Point of Acquisition References
|